Template:SubstanceBox/4-AcO-MET: Difference between revisions
>Tracer Grammatics |
>Mrtryptamine Changed the dosages because they don't accurately reflect what is reported by any other source, including Shulgin and Erowid (4-ho-met) |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 40: | Line 40: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=4-AcO-MET, 4-Acetoxy-MET, Metacetin, O-Acetylmetocin | |NameCommon=[[common name::4-AcO-MET]], [[common name::4-Acetoxy-MET]], [[common name::Metacetin]], [[common name::O-Acetylmetocin]] | ||
|NameSubstitution=4-Acetoxy-N-methyl-N-ethyltryptamine | |NameSubstitution=4-Acetoxy-N-methyl-N-ethyltryptamine | ||
|NameSystematic=3-(2-Ethyl(methyl)aminoethyl)-1H-indol-4-yl acetate | |NameSystematic=3-(2-Ethyl(methyl)aminoethyl)-1H-indol-4-yl acetate | ||
Line 71: | Line 71: | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose:: | |OralROA_Threshold=[[Oral threshold dose::2]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose:: | |OralROA_Light=[[Oral min light dose::5]] - [[Oral max light dose::10]] mg | ||
|OralROA_Common=[[Oral min common dose:: | |OralROA_Common=[[Oral min common dose::8]] - [[Oral max common dose::15]] mg | ||
|OralROA_Strong=[[Oral min strong dose:: | |OralROA_Strong=[[Oral min strong dose::10]] - [[Oral max strong dose::20]] mg | ||
|OralROA_Heavy=[[Oral heavy dose:: | |OralROA_Heavy=[[Oral heavy dose::25]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= |